mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |